Which ETFs hold DASHENLIN PHARMACEUTICAL G A?
603233 is held by 1 of the 504 ETFs we cover. The heaviest allocation is SPEM at 0.0%. The median weight across all funds holding it is 0.0%.
- Covered ETFs Holding It
- 1
- Heaviest Allocation
- 0.00%in SPEM
- Median Weight
- 0.00%across funds that hold it
Funds Holding 603233(1)
| ETF | |||||||
|---|---|---|---|---|---|---|---|
| SPEMState Street® SPDR® Portfolio Emerging Markets ETF | 0.00% | 0.07% | $17.4B | 2.48% | +13.1% | +22.8% | +7.2% |
Expense = net expense ratio from the fund's latest SEC prospectus filing. YTD/1Y/5Y are trailing total returns including dividends (5Y annualized, as of 2026-08-07). Past performance does not predict future results. Sort by any column.
Frequently Asked Questions
Which ETF has the most 603233 exposure?
SPEM has the heaviest 603233 allocation of the ETFs we cover, at 0.00% of its portfolio, based on the fund's latest SEC-reported holdings.
How many ETFs hold 603233?
1 of the 504 ETFs we cover hold DASHENLIN PHARMACEUTICAL G A (603233). The median weight across those funds is 0.00%.
What is the cheapest ETF that holds 603233?
SPEM has the lowest expense ratio among covered ETFs holding 603233, at 0.07% per year.
What is the largest ETF that holds 603233?
SPEM (State Street® SPDR® Portfolio Emerging Markets ETF) is the largest covered ETF holding 603233, with $17.4B in assets and a 0.00% position.
Keep Exploring
Look up another stock or compare two of these ETFs to see how much they overlap beyond 603233.